*ST三圣：根据《重整投资协议》、《重整计划》，控股股东将适时择机向上市公司注入自身医药资产

Group 1 - The core viewpoint of the article is that *ST San Sheng (002742.SZ) is planning to inject its pharmaceutical assets into the company to strengthen its core competitiveness in the pharmaceutical sector [2] - The company has no current plans to inject chemical assets or pursue a public listing as a whole [2] - The company encourages stakeholders to refer to the relevant sections of the "Reorganization Plan" regarding operational strategies [2]